comparemela.com

Latest Breaking News On - Awakn - Page 2 : comparemela.com

Awakn Life Sciences Corp : Awakn Life Sciences Signs Its First Licensing Partnership Agreement in Europe

Awakn Will License its Protocols for Treating Addiction and Mental Health to a Healthcare Consortium to Help Accelerate Their Development of a Chain of Clinics in Portugal Toronto, Ontario (Newsfile

United statesDennis riedlGordo whittakerAnthony tennysonLinkedin facebookAwakn life sciencesMental healthAwakn life sciences corpHealthcare consortium to help accelerate their developmentLicensing partnershipNewsfile corpEuropean unionAwakn will licenseTreating addictionHealthcare consortiumHelp accelerate their development

Awakn Life Sciences Corp : Awakn Life Sciences Announces the Opening of Its Fourth Clinic

Awakn Clinics Trondheim is its second clinic in Norway Toronto, Ontario (Newsfile Corp. - February 14, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a biotechnology

United statesUnited kingdomGordo whittakerIngrid castbergLars lienAnthony tennysonLinkedin facebookAwakn life sciencesNewsfile corpAwakn life sciences corpNorwegian psychiatric associationAwakn clinics trondheimLife sciencesAlcohol use disorderClinics trondheimRegional director

Awakn Life Sciences Corp : Awakn Life Sciences Responds to OTC Markets Request on Recent Promotional Activity

Toronto, Ontario (Newsfile Corp. - February 8, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company developing therapeutics to treat addiction with

United kingdomUnited statesGordo whittakerAnthony tennysonLinkedin facebookSchwierige zeitenAwakn life sciencesNewsfile corpAwakn life sciences corpGroup incGeelon coLife sciencesAlcohol use disorderStock street wireJust capital consultingUnited states securities act

Awakn Life Sciences Corp : Awakn Life Sciences Initiates Feasibility Study for MDMA Using Catalent s Zydis Orally Disintegrating Tablet (ODT) Technology

Toronto, Ontario (Newsfile Corp. - February 9, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a biotechnology company developing therapeutics to treat addiction with

Gordo whittakerAnthony tennysonLinkedin facebookSchwierige zeitenShaun mcnultyAwakn life sciencesNewsfile corpAwakn life sciences corpLife sciencesAlcohol use disorderAwakn life

Awakn Life Sciences Corp : Awakn Life Sciences Granted Fast-Track Designation from UK Regulator for Ketamine-Assisted Therapy for Alcohol Use Disorder

Designation Aims to Accelerate Time to Market Toronto, Ontario (Newsfile Corp. - February 7, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a biotechnology company

United statesGordo whittakerCelia morganAnthony tennysonLinkedin facebookSchwierige zeitenAwakn life sciencesExeter universityNational institute of healthAwakn life sciences corpRegulatory agencyNational health serviceNewsfile corpDesignation aimsAccelerate timeLife sciences

vimarsana © 2020. All Rights Reserved.